title: Catalytic immunoglobulin gene delivery in a mouse model of Alzheimer's disease: prophylactic and therapeutic applications.
abstract: Accumulation of amyloid beta-peptide (Aβ) in the brain is hypothesized to be a causal event leading to dementia in Alzheimer's disease (AD). Aβ vaccination removes Aβ deposits from the brain. Aβ immunotherapy, however, may cause T cell- and/or Fc-receptor-mediated brain inflammation and relocate parenchymal Aβ deposits to blood vessels leading to cerebral hemorrhages. Because catalytic antibodies do not form stable immune complexes and Aβ fragments produced by catalytic antibodies are less likely to form aggregates, Aβ-specific catalytic antibodies may have safer therapeutic profiles than reversibly-binding anti-Aβ antibodies. Additionally, catalytic antibodies may remove Aβ more efficiently than binding antibodies because a single catalytic antibody can hydrolyze thousands of Aβ molecules. We previously isolated Aβ-specific catalytic antibody, IgVL5D3, with strong Aβ-hydrolyzing activity. Here, we evaluated the prophylactic and therapeutic efficacy of brain-targeted IgVL5D3 gene delivery via recombinant adeno-associated virus serotype 9 (rAAV9) in an AD mouse model. One single injection of rAAV9-IgVL5D3 into the right ventricle of AD model mice yielded widespread, high expression of IgVL5D3 in the unilateral hemisphere. IgVL5D3 expression was readily detectable in the contralateral hemisphere but to a much lesser extent. IgVL5D3 expression was also confirmed in the cerebrospinal fluid. Prophylactic and therapeutic injection of rAAV9-IgVL5D3 reduced Aβ load in the ipsilateral hippocampus of AD model mice. No evidence of hemorrhages, increased vascular amyloid deposits, increased proinflammatory cytokines, or infiltrating T-cells in the brains was found in the experimental animals. AAV9-mediated anti-Aβ catalytic antibody brain delivery can be prophylactic and therapeutic options for AD.
authors.affiliation: Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL, 61656, USA.
authors.forename: Jinghong
authors.initials: J
authors.lastname: Kou
authors.forename: Junling
authors.initials: J
authors.lastname: Yang
authors.forename: Jeong-Eun
authors.initials: JE
authors.lastname: Lim
authors.forename: Abhinandan
authors.initials: A
authors.lastname: Pattanayak
authors.forename: Min
authors.initials: M
authors.lastname: Song
authors.forename: Stephanie
authors.initials: S
authors.lastname: Planque
authors.forename: Sudhir
authors.initials: S
authors.lastname: Paul
authors.forename: Ken-Ichiro
authors.initials: K
authors.lastname: Fukuchi
mesh_terms: D000544:Alzheimer Disease / Q000134:cerebrospinal fluid / Q000150:complications / Q000517:prevention & control* / Q000628:therapy*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D055162:Biocatalysis / Q000187:drug effects; D016657:Cerebral Amyloid Angiopathy / Q000209:etiology / Q000473:pathology; D002543:Cerebral Hemorrhage / Q000209:etiology / Q000473:pathology; D000229:Dependovirus / Q000378:metabolism; D004195:Disease Models, Animal; D005803:Genes, Immunoglobulin; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000378:metabolism; D057809:HEK293 Cells; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000473:pathology; D007267:Injections; D008810:Mice, Inbred C57BL; D017628:Microglia / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D019579:Neocortex / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D058225:Plaque, Amyloid / Q000378:metabolism; D012995:Solubility
chemical_list: D016229:Amyloid beta-Peptides; D000906:Antibodies
references.citation: Hum Gene Ther. 2013 May;24(5):526-32
references.pmid: 23517473
references.citation: Gene Ther. 2011 May;18(5):517-27
references.pmid: 21326331
references.citation: Mol Ther. 2003 Dec;8(6):911-7
references.pmid: 14664793
references.citation: Neurobiol Aging. 2004 Sep;25(8):1023-32
references.pmid: 15212827
references.citation: Immun Ageing. 2013 May 11;10(1):18
references.pmid: 23663286
references.citation: J Alzheimers Dis. 2011;27(1):23-38
references.pmid: 21709371
references.citation: PLoS One. 2013;8(3):e59626
references.pmid: 23555730
references.citation: Mol Ther. 2011 May;19(5):860-9
references.pmid: 21326216
references.citation: Biochem J. 2006 May 1;395(3):473-81
references.pmid: 16422668
references.citation: Mol Ther. 2009 Aug;17(8):1381-6
references.pmid: 19471248
references.citation: J Neurosci. 2009 Mar 18;29(11):3453-62
references.pmid: 19295151
references.citation: Nature. 2000 Dec 21-28;408(6815):979-82
references.pmid: 11140685
references.citation: J Neurosci. 2004 Jan 28;24(4):991-8
references.pmid: 14749444
references.citation: J Neurochem. 2002 Apr;81(2):229-36
references.pmid: 12064470
references.citation: Nat Biotechnol. 2009 Jan;27(1):59-65
references.pmid: 19098898
references.citation: Nature. 1999 Jul 8;400(6740):173-7
references.pmid: 10408445
references.citation: Neurobiol Aging. 2002 Nov-Dec;23(6):1001-8
references.pmid: 12470795
references.citation: Arch Neurol. 2012 Feb;69(2):198-207
references.pmid: 21987394
references.citation: Mol Ther. 2009 Jul;17(7):1187-96
references.pmid: 19367261
references.citation: Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12145-50
references.pmid: 19581601
references.citation: J Neuroinflammation. 2004 Dec 08;1(1):24
references.pmid: 15588287
references.citation: Ann Neurol. 2013 Apr;73(4):449-58
references.pmid: 23625526
references.citation: J Mol Biol. 1995 Nov 10;253(5):658-64
references.pmid: 7473741
references.citation: J Neurosci. 2008 Nov 5;28(45):11650-61
references.pmid: 18987201
references.citation: J Neurosci. 2007 Sep 12;27(37):9928-40
references.pmid: 17855607
references.citation: Gene. 1991 Dec 15;108(2):193-9
references.pmid: 1660837
references.citation: J Neurosci. 2000 Dec 1;20(23):8745-9
references.pmid: 11102481
references.citation: Nat Med. 2000 Aug;6(8):916-9
references.pmid: 10932230
references.citation: Neurology. 2003 Jul 8;61(1):46-54
references.pmid: 12847155
references.citation: Nature. 2000 Dec 21-28;408(6815):982-5
references.pmid: 11140686
references.citation: Nat Genet. 2006 Jan;38(1):11-2
references.pmid: 16380721
references.citation: Autoimmun Rev. 2008 May;7(5):391-7
references.pmid: 18486927
references.citation: Nat Med. 2002 Nov;8(11):1270-5
references.pmid: 12379846
references.citation: Expert Opin Biol Ther. 2013 Jul;13(7):1075-84
references.pmid: 23574434
references.citation: Sci Rep. 2013;3:1472
references.pmid: 23503602
references.citation: Neurobiol Dis. 2004 Feb;15(1):11-20
references.pmid: 14751766
references.citation: Neurobiol Dis. 2006 Sep;23(3):502-11
references.pmid: 16766200
references.citation: Nature. 2002 Jan 31;415(6871):462
references.pmid: 11823817
references.citation: Neurology. 2009 Dec 15;73(24):2061-70
references.pmid: 19923550
references.citation: Mol Ther. 2006 Mar;13(3):528-37
references.pmid: 16413228
references.citation: Pharmacol Ther. 2013 Sep;139(3):313-26
references.pmid: 23644076
references.citation: Biochem J. 2000 Oct 15;351 Pt 2:509-16
references.pmid: 11023838
references.citation: J Neurosci. 2012 Jul 11;32(28):9677-89
references.pmid: 22787053
references.citation: J Neuroimmunol. 2012 Mar;244(1-2):70-83
references.pmid: 22326143
references.citation: Methods. 2002 Oct;28(2):158-67
references.pmid: 12413414
references.citation: Peptides. 2002 Dec;23(12):2223-6
references.pmid: 12535702
references.citation: Science. 2002 Nov 15;298(5597):1379
references.pmid: 12434053
references.citation: J Neuropathol Exp Neurol. 2006 Nov;65(11):1040-8
references.pmid: 17086100
references.citation: Mol Ther. 2003 Jun;7(6):839-50
references.pmid: 12788658
references.citation: Nature. 2012 Sep 6;489(7414):13-4
references.pmid: 22962697
references.citation: Arch Neurol. 2012 Aug;69(8):1002-10
references.pmid: 22473769
references.citation: Exp Gerontol. 2002 Jul;37(7):943-8
references.pmid: 12086704
references.citation: Mol Ther. 2011 Jun;19(6):1025-33
references.pmid: 21386820
references.citation: Lancet Neurol. 2010 Apr;9(4):363-72
references.pmid: 20189881
references.citation: J Neurosci. 2005 Jan 19;25(3):629-36
references.pmid: 15659599
references.citation: Biochem Biophys Res Commun. 2006 May 26;344(1):79-86
references.pmid: 16630540
references.citation: Ann Neurol. 2009 Jan;65(1):24-31
references.pmid: 19194878
references.citation: Brain Pathol. 2004 Jan;14(1):11-20
references.pmid: 14997933
references.citation: Neurology. 2005 Jan 11;64(1):94-101
references.pmid: 15642910
references.citation: Hum Mol Genet. 2004 Jan 15;13(2):159-70
references.pmid: 14645205
references.citation: J Neurosci Res. 2002 Oct 15;70(2):249-55
references.pmid: 12271474
references.citation: J Biol Chem. 2008 Dec 26;283(52):36724-33
references.pmid: 18974093